Literature DB >> 17206668

Contribution of genetic and environmental factors in the pathogenesis of Crohn's disease in a large family with multiple cases.

Marie Joossens1, Marc Simoens, Séverine Vermeire, Xavier Bossuyt, Karel Geboes, Paul Rutgeerts.   

Abstract

BACKGROUND: A large family of Moroccan immigrants was investigated. In this family the father developed Crohn's disease (CD) after moving from Morocco to Belgium and successively 4 of his 8 children subsequently developed CD. There was no previous history of familial CD.
METHODS: The family was interviewed at their home and an elaborated questionnaire was completed. The food and sanitation characteristics of the family were investigated. Moreover, serological markers were tested in all family members, including ASCA, ASCAg, ALCA, ACCA, Omp, and ANCA, using enzyme-linked immunosorbent assay and indirect immunofluorescence. Genetic variants in CARD15, TLR4, NOD1, CARD8, and DLG5 associated with CD were tested as well. The complete medical history of all patients was reviewed.
RESULTS: There were no known genetic variants associated with CD in this family. None of the serological antibodies could discriminate between patients and unaffected family members, although the antibody titers were higher in diseased family members as compared with the healthy family members.
CONCLUSION: The occurrence of 5 new cases of CD within 1 Moroccan family after immigration to Belgium cannot be explained by the known genetic susceptibility factors, and thus suggests a major environmental factor probably not related to sanitation in childhood.

Entities:  

Mesh:

Year:  2007        PMID: 17206668     DOI: 10.1002/ibd.20086

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  9 in total

Review 1.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 2.  Th9 cells in inflammatory bowel diseases.

Authors:  Benno Weigmann; Markus F Neurath
Journal:  Semin Immunopathol       Date:  2016-11-11       Impact factor: 9.623

3.  Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.

Authors:  Ryan Ungaro; Helena L Chang; Justin Côté-Daigneault; Saurabh Mehandru; Ashish Atreja; Jean-Frederic Colombel
Journal:  Am J Gastroenterol       Date:  2016-06-14       Impact factor: 10.864

Review 4.  Epidemiology of intrafamilial inflammatory bowel disease throughout Europe.

Authors:  Maria Teresa Arias-Loste; Beatriz Castro; Montserrat Rivero; Javier Crespo
Journal:  Ann Gastroenterol       Date:  2012

Review 5.  Making sense of the cause of Crohn's - a new look at an old disease.

Authors:  Anthony W Segal
Journal:  F1000Res       Date:  2016-10-12

6.  Eosinophilic colitis in children.

Authors:  Urszula Grzybowska-Chlebowczyk; Sabina Horowska-Ziaja; Maciej Kajor; Sabina Więcek; Wojciech Chlebowczyk; Halina Woś
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

Review 7.  Helminth Therapy for Immune-Mediated Inflammatory Diseases: Current and Future Perspectives.

Authors:  Wenjie Shi; Ning Xu; Xuelin Wang; Isabelle Vallée; Mingyuan Liu; Xiaolei Liu
Journal:  J Inflamm Res       Date:  2022-01-21

Review 8.  The role of Klebsiella in Crohn's disease with a potential for the use of antimicrobial measures.

Authors:  Taha Rashid; Alan Ebringer; Clyde Wilson
Journal:  Int J Rheumatol       Date:  2013-10-10

Review 9.  Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy.

Authors:  Rangnath Mishra; Punita Dhawan; Anand S Srivastava; Amar B Singh
Journal:  World J Stem Cells       Date:  2020-10-26       Impact factor: 5.326

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.